Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Kossenkov, Andrew V ^a   Dawany, Noor ^a   Evans, Tracey L ^b   Kucharczuk, John C ^b   Albelda, Steven M ^b   Showe, Louise C ^a   Showe, Michael K ^a   Vachani, Anil ^b  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS2 GENE; ADULT; AGED; ARTICLE; ASS GENE; B LYMPHOCYTE; BF194881 GENE; BF846242 GENE; BONE MARROW CELL; BU854460 GENE; C4BPB GENE; C5ORF20 GENE; CANCER STAGING; CANCER SURVIVAL; CCNE2 GENE; CLEC4C GENE; CONTROLLED STUDY; CORO6 GENE; CUTL2 GENE; DENDRITIC CELL; FAM20A GENE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INADL GENE; KIF15 GENE; LOC390372 GENE; LOC650200 GENE; LRP8 GENE; LUNG NON SMALL CELL CANCER; LYMPHOID CELL; MAJOR CLINICAL STUDY; MALE; MMP1 GENE; ONCOGENE; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; SCT GENE; SLC1A3 GENE; T LYMPHOCYTE; TCEAL4 GENE; TCRVA2 GENE; THEDC1 GENE; TSPAN14 GENE; ZNF662 GENE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG; LUNG TUMOR; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY; PROGNOSIS; SURVIVAL;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84859047790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034392     Document Type: Article

References (32)

1. ACS (2010) Cancer Facts and Figures 2010 Atlanta American Cancer Society.
2. Jemal A, Ward E, Hao Y, Thun M, (2005) Trends in the Leading Causes of Death in the United States, 1970-2002. JAMA 294: 1255-1259.
3. Dubey S, Powell CA, (2008) Update in Lung Cancer 2007. Am J Respir Crit Care Med 177: 941-946.
4. Subramanian J, Simon R, (2010) Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use? Journal of the National Cancer Institute 102: 464-474.
5. Kossenkov AV, Vachani A, Chang C, Nichols C, Billouin S, et al. (2011) Resection of Non-Small Cell Lung Cancers Reverses Tumor-Induced Gene Expression Changes in the Peripheral Immune System. Clin Cancer Res.
6. Showe MK, Vachani A, Kossenkov AV, Yousef M, Nichols C, et al. (2009) Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res 69: 9202-9210.
7. Storey JD, Tibshirani R, (2003) Statistical methods for identifying differentially expressed genes in DNA microarrays. Methods Mol Biol 224: 149-157.
8. Goeman JJ, (2010) L1 penalized estimation in the Cox proportional hazards model. Biom J 52: 70-84.
9. Gonen M, Heller G, (2005) Concordance Probability and Discriminatory Power in Proportional Hazards Regression New York The Berkeley Electronic Press.
10. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
11. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
12. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102: 15545-15550.
13. Abbas AR, Baldwin D, Ma Y, Ouyang W, Gurney A, et al. (2005) Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun 6: 319-331.
14. Abbas AR, Wolslegel K, Seshasayee D, Modrusan Z, Clark HF, (2009) Deconvolution of Blood Microarray Data Identifies Cellular Activation Patterns in Systemic Lupus Erythematosus. PLoS ONE 4: e6098.
15. Kadara H, Behrens C, Yuan P, Solis L, Liu D, et al. (2011) A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis. Clinical Cancer Research 17: 1490-1501.
16. Chen A, Luo M, Yuan G, (2008) Complementary analysis of microRNA and mRNA expression during phorbol 12-myristate 13-acetate (TPA)-induced differentiation of HL-60 cells. Biotechnol Lett 30: 2045-2052.
17. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, et al. (2011) Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 91: 579-587.
18. Boeri M, Verri C, Conte D, Roz L, Modena P, et al. (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 108: 3713-3718.
19. Hu Z, Chen X, Zhao Y, Tian T, Jin G, et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-1726.
20. Pardoll D, (2003) Does the immune system see tumors as foreign or self? Annu Rev Immunol 21: 807-839.
21. Diaz-Montero C, Salem M, Nishimura M, Garrett-Mayer E, Cole D, et al. (2009) Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 58: 49-59.
22. Gabrilovich DI, Nagaraj S, (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174.
23. Gregory AD, Houghton AM, (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 71: 2411-2416.
24. Schmielau J, Finn OJ, (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res 61: 4756-4760.
25. Trellakis S, Bruderek K, Dumitru CA, (2011) Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells, and expansion in advanced disease. Int J Ca.
26. Chen G, Wang Z, Liu XY, Liu FY, (2011) High-level CXCR4 expression correlates with brain-specific metastasis of non-small cell lung cancer. World J Surg 35: 56-61.
27. Yamada M, Kubo H, Kobayashi S, Ishizawa K, He M, et al. (2011) The increase in surface CXCR4 expression on lung extravascular neutrophils and its effects on neutrophils during endotoxin-induced lung injury. Cell Mol Immunol 8: 305-314.
28. Leone V, D'Angelo D, Rubio I, de Freitas PM, Federico A, et al. (2011) MiR-1 Is a Tumor Suppressor in Thyroid Carcinogenesis Targeting CCND2, CXCR4, and SDF-1{alpha}. J Clin Endocrinol Metab.
29. Stachon A, Böning A, Krismann M, Weisser H, Laczkovics A, et al. (2001) Prognostic Significance of the Presence of Erythroblasts in Blood after Cardiothoracic Surgery. Clinical Chemistry and Laboratory Medicine 39: 239-243.
30. van den Akker E, Satchwell TJ, Pellegrin S, Daniels G, Toye AM, (2010) The majority of the in vitro erythroid expansion potential resides in CD34- cells, outweighing the contribution of CD34+ cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica 95: 1594-1598.
31. Le QT, Chen E, Salim A, Cao H, Kong CS, et al. (2006) An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res 12: 1507-1514.
32. Varlotto J, Stevenson MA, (2005) Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys 63: 25-36.